BAXNYSESEC EDGAREDGAR

BAXTER INTERNATIONAL INC

Surgical & Medical Instruments & Apparatus·DEERFIELD, IL·FY end 12/31·CIK 10456
CEO Pay Ratio
257:1
José E. Almeida
CEO Total Comp
$18.1M
José E. Almeida
Median Employee
Revenue
$11.2B
FY 2025
Net Income
-$957.0M
FY 2025
Free Cash Flow
FY 2025
Net Margin
-8.5%
Insider Net (180d)
$0
0 buys / 0 sales

CEO Pay Accountability

CEO comp as % of net income
-3.53%
For every $1,000 of profit, $-35.29 flows to the CEO.
CEO comp as % of buybacks
No buyback data for the most recent fiscal year.

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$11.2B$2.8B$3.9B$15.1B$12.8B
Gross Profit$3.4B$959.0M$1.5B$5.4B$5.1B
Operating Income-$308.0M$14.0M$390.0M-$1.9B$1.7B
Net Income-$957.0M-$512.0M$245.0M-$2.4B$1.3B
Operating CF$845.0M$1.0B$1.7B$1.2B$2.2B
Capex
Free Cash Flow
Buybacks$0$0$32.0M$600.0M
Dividends$348.0M$590.0M$586.0M$573.0M$530.0M
Gross Margin30.1%34.8%37.9%35.7%39.9%
Operating Margin-2.7%0.5%10.0%-12.9%13.4%
Net Margin-8.5%-18.6%6.3%-16.1%10.0%
FCF Margin
R&D / Revenue4.6%21.4%17.2%4.0%4.2%
Effective Tax-78.2%-12.8%33.0%-2.9%12.3%
Debt / Equity1.541.891.652.861.96
Buybacks / FCF

Named Executive Officers

FY 2024
ExecutiveSalaryStockOptionsBonus / Inc.OtherTotal
José E. AlmeidaFormer Chair of the Board, President and Chief Executive Officer
$1.3M$14.3M$2.0M$435.6K$18.1M
Christopher TothFormer Executive Vice President and Group President, Kidney Care
$1.0M$5.1M$1.4M$78.2K$7.6M
Heather KnightExecutive Vice President, Chief Operating Officer and Interim Group President, Medical Products & Therapies
$883.3K$4.6M$1.0M$66.5K$6.6M
Joel GradeExecutive Vice President and Chief Financial Officer
$810.0K$4.3M$1.3M$62.2K$6.5M
Alok SonigExecutive Vice President and Group President, Pharmaceuticals
$787.5K$3.6M$904.0K$71.0K$5.3M